The Örebro Severe Traumatic Brain Injury Registry

Starting soon

Conditions studied: Severe Traumatic Brain Injury, Severe Brain Injury, Ischemic Stroke, Intracerebral Hemorrhage

In brief

Traumatic brain injury and other severe brain injuries requiring neurointensive care are associated with high mortality, long-term disability and substantial societal burden. Despite advances in critical care, outcomes after severe brain injury remain difficult to predict and secondary brain injury plays a major role in determining prognosis. The Örebro Severe Brain Injury Database (ÖrSBID) is a prospective observational registry that aims to systematically collect detailed clinical, physiological, imaging and biological data from adult patients with severe brain injury requiring care at the neurointesive care unit or neurointermediate care unit at Örebro University Hospital. The purpose of the registry is to enable deep phenotyping of severe brain injury, improve understanding of secondary injury mechanisms, support outcome prediction and provide a platform for longitudinal follow-up and future research. No experimental interventions are performed as part of the study.

Key facts

Study ID

NCT07398274

Run by

András Zoltán Buki

People needed

200

Starts

2026-02-08

Expected to finish

2028-02-15

Last updated by the study team

2026-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 16 years
• Severe traumatic brain injury or other severe brain injury requiring neurointensive or neurointermediate care
• Admission to Örebro University Hospital

You may not qualify if…

• Age < 16 years < 90 years
• Non-survivable brain injury
• Patients not requiring neurointensive or neurointermediate care
• Declinced consent by patient or legal representative

Where it is running

• Örebro University Hospital — Örebro, Örebro County, Sweden

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.